Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A van Dam

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Journal of Clinical Pathology|October 1, 1994
Expression of c-erbB-2, c-myc, and c-ras oncoproteins, insulin-like growth factor receptor I, and epidermal growth factor receptor in ovarian carcinomaP A van Dam, I B Vergote, D G Lowe, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 16, 2011
VEGF-A-independent and angiogenesis-dependent tumour growth in patients with metastatic breast cancerX Bich Trinh, P A van Dam, P B Vermeulen, et al.
Breast (Edinburgh, Scotland)|September 5, 2020
A high neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are associated with a worse outcome in inflammatory breast cancerC Van Berckelaer, M Van Geyt, S Linders, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 14, 2001
The importance of biological factors (bcl-2, bax, p53, PCNA, MI, HPV and angiogenesis) in invasive cervical cancerW A Tjalma, J J Weyler, J J Bogers, et al.
Facts, Views & Vision in Obgyn|July 16, 2015
A cross-sectional, multicentre, epidemiological study on human papillomavirus (HPV) type distribution in adult women diagnosed with invasive cervical cancer in BelgiumW A A Tjalma, X B Trinh, M Rosenlund, et al.
British Journal of Cancer|February 26, 2009
The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancerX B Trinh, W A A Tjalma, P B Vermeulen, et al.
British Journal of Cancer|April 7, 2011
Circulating tumour cells in the central and the peripheral venous compartment in patients with metastatic breast cancerD J E Peeters, G G Van den Eynden, P-J van Dam, et al.
British Journal of Cancer|December 25, 2013
Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypesD J E Peeters, P-J van Dam, G G M Van den Eynden, et al.
Oncology Reports|December 3, 2011
A phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancerX B Trinh, L Sas, S J Van Laere, et al.
British Journal of Cancer|March 9, 2013
Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sortingD J E Peeters, B De Laere, G G Van den Eynden, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Journal of Clinical Pathology|October 1, 1994
Expression of c-erbB-2, c-myc, and c-ras oncoproteins, insulin-like growth factor receptor I, and epidermal growth factor receptor in ovarian carcinomaP A van Dam, I B Vergote, D G Lowe, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 16, 2011
VEGF-A-independent and angiogenesis-dependent tumour growth in patients with metastatic breast cancerX Bich Trinh, P A van Dam, P B Vermeulen, et al.
Breast (Edinburgh, Scotland)|September 5, 2020
A high neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are associated with a worse outcome in inflammatory breast cancerC Van Berckelaer, M Van Geyt, S Linders, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 14, 2001
The importance of biological factors (bcl-2, bax, p53, PCNA, MI, HPV and angiogenesis) in invasive cervical cancerW A Tjalma, J J Weyler, J J Bogers, et al.
Facts, Views & Vision in Obgyn|July 16, 2015
A cross-sectional, multicentre, epidemiological study on human papillomavirus (HPV) type distribution in adult women diagnosed with invasive cervical cancer in BelgiumW A A Tjalma, X B Trinh, M Rosenlund, et al.
British Journal of Cancer|February 26, 2009
The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancerX B Trinh, W A A Tjalma, P B Vermeulen, et al.
British Journal of Cancer|April 7, 2011
Circulating tumour cells in the central and the peripheral venous compartment in patients with metastatic breast cancerD J E Peeters, G G Van den Eynden, P-J van Dam, et al.
British Journal of Cancer|December 25, 2013
Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypesD J E Peeters, P-J van Dam, G G M Van den Eynden, et al.
Oncology Reports|December 3, 2011
A phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancerX B Trinh, L Sas, S J Van Laere, et al.
British Journal of Cancer|March 9, 2013
Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sortingD J E Peeters, B De Laere, G G Van den Eynden, et al.
Pageof 6